Asia Pacific Aesthetics Market Summary
As per Market Research Future Analysis, the Asia Pacific Aesthetics market is projected to reach USD 4.3 Billion by 2032, growing at a CAGR of 9.9% from 2023 to 2032. The market is driven by increasing expenditure on cosmetic surgeries, with Japan leading in per capita cosmetic expenditure at approximately USD 174 in 2015. The rising prevalence of skin diseases, such as acne affecting about 90% of adolescents, and the demand for aesthetic procedures like liposuction and hair transplantation among the obese and geriatric populations further fuel market growth. However, high procedural costs and the need for trained physicians may restrain growth. Japan holds the largest market share, followed by India and China, with Australia having the lowest share due to high costs and a lack of skilled practitioners.
Key Market Trends & Highlights
Key trends influencing the Asia Pacific Aesthetics market include rising demand for aesthetic procedures and significant regional disparities.
- Asia Pacific Aesthetics market projected to reach USD 4.3 Billion by 2032.
- CAGR of 9.9% during the forecast period 2023-2032.
- Japan's per capita cosmetic expenditure was about USD 174 in 2015.
- 90% of adolescents in the region are estimated to be affected by acne.
Market Size & Forecast
| Market Size | USD 4.3 Billion by 2032 |
| CAGR | 9.9% from 2023 to 2032 |
| Largest Regional Market | Japan |
| Second Largest | India |
Major Players
Cutera (U.S.), Alma Lasers (Israel), ALLERGAN (Ireland), Lumenis (Israel), Syneron Medical Ltd. (U.S.), PhotoMedex, Inc. (U.S.), Cynosure, Inc. (U.S.), Galderma S.A. (Switzerland), Solta Medical, Inc. (Canada), Sanofi (France), Mentor Worldwide LLC (U.S.), ZELTIQ Aesthetics, Inc. (U.S.), Merz Pharma (Germany), Integra Lifesciences (U.S.), Johnson & Johnson Services, Inc. (U.S.)
